We are live on
!
Find out more
GA
Geneva Advisors Portfolio holdings
AUM
$5.81B
Turnover
22.5%
1-Year Est. Return
23.71%
This Fund
S&P 500
This Quarter
Est. Return
+13.79%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.82B
AUM Growth
+$522M
(+12%)
Cap. Flow
+$73.4M
Cap. Flow
% of AUM
1.52%
Top 10 Holdings %
Top 10 Hldgs %
20.44%
Holding
604
New
109
Increased
179
Reduced
173
Closed
43
Avg Time Held
0.2
years
Top 10 Avg Time Held
0.1
years
Top 20 Avg Time Held
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$48.8M |
| 2 |
Comcast
CMCSA
|
+$46.9M |
| 3 |
Avery Dennison
AVY
|
+$38.5M |
| 4 |
Middleby
MIDD
|
+$33M |
| 5 |
LKQ Corp
LKQ
|
+$32.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MON
Monsanto Co
MON
|
+$63.1M |
| 2 |
T. Rowe Price
TROW
|
+$47.7M |
| 3 |
Intuitive Surgical
ISRG
|
+$39M |
| 4 |
Plains All American Pipeline
PAA
|
+$39M |
| 5 |
Sherwin-Williams
SHW
|
+$38.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 17.65% |
| 2 | Financials | 14.81% |
| 3 | Industrials | 14.31% |
| 4 | Technology | 11.57% |
| 5 | Energy | 10.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
TWC
401
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
| $208K | ﹤0.01% |
+1,867
| New | +$210K |
2013 Q3
0 quarters
|
|
402
SFL Corp
SFL
$1.73B
| $204K | ﹤0.01% |
+13,350
| New | +$209K |
2013 Q3
0 quarters
|
|
|
PVTB
403
DELISTED
PrivateBancorp Inc
PVTB
| $202K | ﹤0.01% |
9,456
| – | – |
2013 Q2
1 quarter
|
|
|
DNDN
404
DELISTED
DENDREON CORPORATION
DNDN
| $193K | ﹤0.01% |
65,980
+44,980
| +214% | +$166K |
2013 Q2
1 quarter
|
|
405
Annaly Capital Management
NLY
$13.9B
| $184K | ﹤0.01% |
+3,981
| New | +$187K |
2013 Q3
0 quarters
|
|
406
Oxford Lane Capital
OXLC
$787M
| $161K | ﹤0.01% |
+2,100
| New | +$168K |
2013 Q3
0 quarters
|
|
|
SVLC
407
DELISTED
SILVERCREST MINES INC ORD SHS (CDA)
SVLC
| $161K | ﹤0.01% |
91,000
+11,000
| +14% | +$19.5K |
2013 Q2
1 quarter
|
|
408
First Majestic Silver
AG
$8.02B
| $130K | ﹤0.01% |
11,000
+1,000
| +10% | +$13.1K |
2013 Q2
1 quarter
|
|
409
Distribution Solutions Group
DSGR
$1.62B
| $130K | ﹤0.01% |
25,170
| – | – |
2013 Q2
1 quarter
|
|
410
DELISTED
BankFinancial
BFIN
| $125K | ﹤0.01% |
14,117
-5,038
| -26% | -$44.5K |
2013 Q2
1 quarter
|
|
411
iShares MSCI Japan ETF
EWJ
$23.3B
| $125K | ﹤0.01% |
2,616
-37
| -1% | -$1.71K |
2013 Q2
1 quarter
|
|
412
Alcoa
AA
$11.6B
| $97K | ﹤0.01% |
4,994
-249
| -5% | -$4.82K |
2013 Q2
1 quarter
|
|
413
MidCap Financial Investment
MFIC
$695M
| $86K | ﹤0.01% |
3,533
| – | – |
2013 Q2
1 quarter
|
|
|
MDW
414
DELISTED
MIDWAY GOLD CORP (CANADA)
MDW
| $80K | ﹤0.01% |
84,100
| – | – |
2013 Q2
1 quarter
|
|
|
PLM
415
DELISTED
PolyMet Mining Corp.
PLM
| $66K | ﹤0.01% |
8,380
+3,380
| +68% | +$27K |
2013 Q2
1 quarter
|
|
|
ARNA
416
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $53K | ﹤0.01% |
+1,000
| New | +$67.1K |
2013 Q3
0 quarters
|
|
417
SiriusXM
SIRI
$9.19B
| $47K | ﹤0.01% |
1,224
-268
| -18% | -$9.98K |
2013 Q2
1 quarter
|
|
418
DELISTED
AMERICAN APPAREL INC COM
APP
| $38K | ﹤0.01% |
29,350
+1,000
| +4% | +$1.69K |
2013 Q2
1 quarter
|
|
419
Fortuna Silver Mines
FSM
$3.2B
| $37K | ﹤0.01% |
10,000
| – | – |
2013 Q2
1 quarter
|
|
|
HZNP
420
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $34K | ﹤0.01% |
+10,000
| New | +$26.4K |
2013 Q3
0 quarters
|
|
|
ELI
421
DELISTED
ELITE PHARMACEUTICAL
ELI
| $31K | ﹤0.01% |
249,890
+50,000
| +25% | +$6.2K |
2013 Q2
1 quarter
|
|
422
NeoGenomics
NEO
$2.14B
| $30K | ﹤0.01% |
10,000
| – | – |
2013 Q2
1 quarter
|
|
423
Denison Mines
DNN
$2.11B
| $27K | ﹤0.01% |
25,000
| – | – |
2013 Q2
1 quarter
|
|
|
TSYS
424
DELISTED
TELECOMMUNICATIONS SYS INC "A"
TSYS
| $25K | ﹤0.01% |
+10,000
| New | +$26.5K |
2013 Q3
0 quarters
|
|
|
GMO
425
DELISTED
General Moly, Inc.
GMO
| $22K | ﹤0.01% |
13,518
| – | – |
2013 Q2
1 quarter
|
|
Similar funds
CAM
DL
TCM
HCM
AL
AT
Geneva Advisors's Q3 2013 Portfolio in Review
As of Q3 2013, Geneva Advisors held 604 positions worth $4.82B, up 12% from $4.3B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Geneva Advisors's Q3 2013 filing shows 109 new, 179 increased, 173 reduced and 43 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 185,591 shares worth $58.1M. The largest sale was Monsanto Co, an estimated $63.1M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 15% a quarter earlier, followed by Financials and Industrials.
- Geneva Advisors's largest Q3 2013 buy was Regeneron Pharmaceuticals: 185,591 shares worth $58.1M.
- Geneva Advisors added most to Comcast in Q3 2013, an estimated $46.9M increase.
- Geneva Advisors's biggest Q3 2013 reduction was Monsanto Co, cutting an estimated $63.1M.
- Geneva Advisors fully exited Valmont Industries in Q3 2013, selling an estimated $36.7M.
- Geneva Advisors's ten largest holdings make up 20% of its $4.82B portfolio in Q3 2013.
- Geneva Advisors opened 109 new positions and closed 43 in Q3 2013.
- Geneva Advisors's portfolio value rose 12% quarter-over-quarter to $4.82B.
Based on Geneva Advisors's 13F filing for Q3 2013, filed 4 Nov 2013.